From Pilots to Real Impact

Established pharma brands often struggle to stay innovative.
In this session, discover how Organon and Globant Enterprise AI built Project ORBIT — a new digital business model that brings innovation, efficiency, and compliance together.
Through a system powered by AI agents and human expertise, Organon leveraged Globant Enterprise AI to transform traditional marketing operations into an orchestrated, data-driven workflow— reducing time-to-market, increasing compliance, and revitalizing established brands.
Dive in to learn how this model redefines pharma engagement and what it takes to bridge the execution gap across complex, regulated industries.

Developing new oncology treatments is a race against time — one defined by long timelines, high costs, and massive data complexity.

In this session, we’ll explore how PharmaMar, a global biopharmaceutical leader in cancer research, partnered with Globant to transform its R&D decision-making through an agentic AI approach.

You’ll discover how this collaboration enables scientists to access and connect decades of preclinical and clinical knowledge with real-time external data — accelerating insights, improving accuracy, and reducing uncertainty across research phases.

We’ll explore Glob.AI OS’s role in enabling this transformation, providing the multi-agent framework that powers PharmaMar’s “co-scientist” system — designed to integrate, validate, and operationalize knowledge across the entire R&D cycle.

From discovery to clinical design, you’ll leave with an inside look at how AI is helping PharmaMar bring life-saving treatments to patients faster — and how human expertise and AI can work together to unlock smarter, faster, and safer R&D decisions.

AI adoption is no longer optional — it’s a business necessity. Yet 95% of AI pilots fail before delivering real results.

In this keynote, Glob.AI OS and Globant CODA’s product leaders — Alejandra Arbat, Eugenio García, and José Lamas, together with Matías Boix — will explore how to move from isolated experimentation to enterprise-scale execution.

Through three complementary perspectives — Builders, Consumers, and Developers — they’ll share how Globant’s product ecosystem enables organizations to create, operate, and scale agentic solutions with governance, collaboration, and purpose.

Discover how companies can turn uncertainty into action, break down silos, and accelerate AI’s impact across every part of the business.